Cargando…

Helicobacter pylori infection among patients with liver cirrhosis

BACKGROUND AND AIM: Inflammatory changes in the stomach caused by Helicobacter pylori indirectly and directly affect liver function. Moreover, the bacteria may worsen the course of the liver cirrhosis. The study aimed at evaluating the incidence of H. pylori infection among patients with liver cirrh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pogorzelska, Joanna, Łapińska, Magda, Kalinowska, Alicja, Łapiński, Tadeusz W., Flisiak, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams And Wilkins 2017
Materias:	Original Articles: Liver Failure
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590811/ https://www.ncbi.nlm.nih.gov/pubmed/28700364 http://dx.doi.org/10.1097/MEG.0000000000000928

Ejemplares similares

Nutritional status in patients with liver cirrhosis
por: Łapiński, Tadeusz Wojciech, et al.
Publicado: (2019)

Erectile dysfunction in cirrhosis is impacted by liver dysfunction, portal hypertension, diabetes and arterial hypertension
por: Paternostro, Rafael, et al.
Publicado: (2018)

Collagen type IV remodelling gender‐specifically predicts mortality in decompensated cirrhosis
por: Lehmann, Jennifer, et al.
Publicado: (2019)

In vitro efficacy of pro‐ and anticoagulant strategies in compensated and acutely ill patients with cirrhosis
por: Lisman, Ton, et al.
Publicado: (2018)

Treatment with non‐selective beta‐blockers affects the systemic inflammatory response to bacterial DNA in patients with cirrhosis
por: Gimenez, Paula, et al.
Publicado: (2018)

Coagulopathy is not predictive of bleeding in patients with acute decompensation of cirrhosis and acute‐on‐chronic liver failure
por: Campello, Elena, et al.
Publicado: (2021)

PNPLA3 I148M (rs738409) genetic variant and age at onset of at-risk alcohol consumption are independent risk factors for alcoholic cirrhosis
por: Burza, Maria Antonella, et al.
Publicado: (2014)

Endoglin in human liver disease and murine models of liver fibrosis—A protective factor against liver fibrosis
por: Alsamman, Muhammad, et al.
Publicado: (2017)

Screening and surveillance of oesophageal varices in patients with HCV‐positive liver cirrhosis successfully treated by direct‐acting antiviral agents
por: Ciancio, Alessia, et al.
Publicado: (2022)

Patient understanding of liver cirrhosis and improvement using multimedia education
por: Goldsworthy, Matthew A, et al.
Publicado: (2017)

Controlled attenuation parameter does not predict hepatic decompensation in patients with advanced chronic liver disease
por: Scheiner, Bernhard, et al.
Publicado: (2018)

Global strategy for the diagnosis and management of acute kidney injury in patients with liver cirrhosis
por: Sanchez, Lukas Otero, et al.
Publicado: (2021)

Influenza A(H1N1)pdm09 vaccine effectiveness and other characteristics associated with hospitalization in chronic liver disease patients
por: Ohfuji, Satoko, et al.
Publicado: (2014)

The value of different CT‐based methods for diagnosing low muscle mass and predicting mortality in patients with cirrhosis
por: Paternostro, Rafael, et al.
Publicado: (2019)

Fibrin clot quality in acutely ill cirrhosis patients: Relation with outcome and improvement with coagulation factor concentrates
por: Blasi, Annabel, et al.
Publicado: (2021)

High plasma levels of betaine, a trimethylamine N‐Oxide‐related metabolite, are associated with the severity of cirrhosis
por: van den Berg, Eline H., et al.
Publicado: (2022)

Acute kidney injury is independently associated with death in patients with cirrhosis
por: Scott, Robert A, et al.
Publicado: (2013)

Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis
por: Arabi, Yaseen M, et al.
Publicado: (2012)

Effect of rifaximin on infections, acute‐on‐chronic liver failure and mortality in alcoholic hepatitis: A pilot study (RIFA‐AH)
por: Jiménez, César, et al.
Publicado: (2022)

Bacterascites: A study of clinical features, microbiological findings, and clinical significance
por: Oey, Rosalie C., et al.
Publicado: (2018)

Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis
por: Cheng, Xiang-Pu, et al.
Publicado: (2016)

An ultrasound image‐based deep multi‐scale texture network for liver fibrosis grading in patients with chronic HBV infection
por: Ruan, Dongsheng, et al.
Publicado: (2021)

Systemic inflammation is linked to liver fibrogenesis in patients with advanced chronic liver disease
por: Simbrunner, Benedikt, et al.
Publicado: (2022)

Improved outcomes following the implementation of a decompensated cirrhosis discharge bundle
por: Smethurst, Katherine, et al.
Publicado: (2021)

Prediction of liver fibrosis severity in alcoholic liver disease by human microfibrillar‐associated protein 4
por: Madsen, Bjørn S., et al.
Publicado: (2020)

The organic solute transporters alpha and beta are induced by hypoxia in human hepatocytes
por: Schaffner, Carlos A, et al.
Publicado: (2015)

Outcomes after placement of a SX‐ELLA oesophageal stent for refractory variceal bleeding—A national multicentre study
por: Pfisterer, Nikolaus, et al.
Publicado: (2018)

Characterization of inflammatory response in hepatorenal syndrome: Relationship with kidney outcome and survival
por: Solé, Cristina, et al.
Publicado: (2019)

Differential fuel utilization in liver transplant recipients and its relationship with non‐alcoholic fatty liver disease
por: Siddiqui, Mohammad S., et al.
Publicado: (2022)

Non‐invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver disease
por: Simbrunner, Benedikt, et al.
Publicado: (2020)

How to diagnose and manage hepatic encephalopathy: a consensus statement on roles and responsibilities beyond the liver specialist
por: Shawcross, Debbie L., et al.
Publicado: (2016)

Safety of direct oral anticoagulants in patients with advanced liver disease
por: Semmler, Georg, et al.
Publicado: (2021)

Prevalence of and risk factors for anaemia in patients with advanced chronic liver disease
por: Scheiner, Bernhard, et al.
Publicado: (2019)

MRI‐defined sarcopenia predicts mortality in patients with chronic liver disease
por: Beer, Lucian, et al.
Publicado: (2020)

Transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Indications and posttransjugular intrahepatic portosystemic shunt complications in 2020
por: Horhat, Adelina, et al.
Publicado: (2021)

Deprescribing medications that may increase the risk of hepatic encephalopathy: A qualitative study of patients with cirrhosis and their doctors
por: Williams, Sydni, et al.
Publicado: (2021)

Liver growth prediction in ALPPS – A multicenter analysis from the international ALPPS registry
por: Lopez‐Lopez, Victor, et al.
Publicado: (2022)

Response to the NCEPOD report: development of a care bundle for patients admitted with decompensated cirrhosis—the first 24 h
por: McPherson, Stuart, et al.
Publicado: (2016)

Clinical characteristics and management of 1572 patients with pyogenic liver abscess: A 12‐year retrospective study
por: Yin, Dalong, et al.
Publicado: (2020)

Low prevalence and disease severity of COVID‐19 in post‐liver transplant recipients—A single centre experience
por: Verma, Anita, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kt3gluefdiotumgc65ikng5ps3